Rock Creek Group, LP Exact Sciences Corp Transaction History

Rock Creek Group, LP

  • $1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$57.56 - $82.54 $482,698 - $692,180
-8,386 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $607,985 - $844,302
8,386 New
8,386 $640,000
Q4 2019

Feb 14, 2020
SELL
$77.66 - $99.74 $77,660 - $99,740
-1,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $89,510 - $118,040
1,000 New
1,000 $118,000

Others Institutions Holding EXAS

# of Institutions
610
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email